ACRS Aclaris Therapeutics Inc

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

$13.95  -0.01 (-0.07%)
As of 07/01/2022 09:44:40 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/07/2015
Outstanding shares:  66,581,903
Average volume:  462,406
Market cap:   $956,116,127
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYV2W40
Valuation   (See tab for details)
PE ratio:   -11.49
PB ratio:   4.78
PS ratio:   148.53
Return on equity:   -44.89%
Net income %:   -1,256.80%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy